Strategic Project Management for Accelerated Drug Development
Expert project leadership to keep complex programs on track, aligned, and moving forward—so you can…
Certara2025 年 12 月 23 日
Pharma positions itself for 2026 amid an evolving US landscape
Explore how U.S. policy changes — including tariffs, onshoring, and Most Favored Nation pricing —…
Certara2025 年 12 月 22 日
A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection
This study synthesizes data from a large body of clinical trials to evaluate rates of…
Certara2025 年 12 月 18 日
Accelerated ADC Approval Through Expert Modeling and Data Rescue
See how Certara rescued complex ADC PK datasets, delivered PopPK, exposure-response modeling, and enabled rapid…
Certara2025 年 12 月 15 日
Merck Advances Pediatric Oncology with Innovative ADC Modeling
Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…
Certara2025 年 12 月 12 日
New Approach Methodologies (NAMs): By the numbers
We outline today’s animal-use landscape, the rise of NAMs, & how the Non-Animal Navigator supports…
Certara2025 年 12 月 10 日
Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings
Certara launches an expedited Pharmacometrics (PMx) Regulatory Submission service that cuts submission timelines in half.
Certara2025 年 12 月 3 日
10 Strategic Foundations for Early Drug Development
探索有效的早期药物研发策略，从容而清晰地推进早期研发工作。Download…
Certara2025 年 11 月 26 日
The stepwise PIP is here to stay: From pilot flexibility to permanent EU regulation
The stepwise Paediatric Investigation Plan (PIP) is a strategic, flexible route for drug developers navigating…
Certara2025 年 11 月 26 日
